Avita Medical | 1811094D - بدهی های جاری

قیمت سهام
1.27
تغییر روزانه
-0.04 -2.69%
ماهیانه
5.42%
سالیانه
-52.97%
Q1 پیش بینی
1.23




بدهی های جاری تغییر دادن تاریخ
Accuray USD 194.61M 2.03M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Clinuvel Pharmaceuticals AUD 25.21M 4.17M 2024-06
Cochlear AUD 558.9M 43.4M 2025-12
CSL USD 4.61B 207M 2025-12
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Mayne Pharma AUD 313.94M 18.28M 2024-06
Medical Developments International AUD 5.56M 2.26M 2025-12
Nanosonics AUD 36.59M 3.2M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 126.16M 18.88M 2025-09
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pacific Edge NZD 7.22M 2.54M 2025-12
Paradigm Biopharmaceuticals AUD 3.23M 2.15M 2025-06
Pharma Mar EUR 93.88M 4.94M 2025-12
Polynovo AUD 23.25M 9.22M 2024-06
PYC Therapeutics AUD 11.01M 1.31M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.25B 7.39M 2025-12
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Telix Pharmaceuticals AUD 231.62M 66.96M 2025-12
Tilray USD 280.3M 18.13M 2025-03
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09